KRAS Testing Gets On Label Of EGFr Products; Will Tests Get To Clinic Soon?

Amgen feels the sales impact from excluding KRAS-positive patients from Vectibix treatment has already occurred, but the firms plans to co-market a test kit shortly.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet